Conclusion
Inhibitors of mammalian DHODH display a variety of inhibition mechanisms and often show a significant species specific efficacy (Table 1). Increasing information about the topochemistry and protein structure of DHODH suggests that the inner-membrane and membrane-associated N-terminal domains of the enzyme, which also distinguish mammalian DHODH from their prokaryotic counterparts14, play a major role in the binding, specificity and efficacy of DHODH inhibitors.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Rawls, J., Knecht, W., Diekert, K., Lill, R., and Loffler, M., 2000, Requirements for the mitochondrial import and localization of dihydroorotate dehydrogenase. Eur. J. Biochem. 267: 2079–2087
Fairbanks, L.D., Bofill, M., Ruckemann, K., and Simmonds, H.A., 1995, Importance of ribonucleotide availability to proliferating T-lymphocytes. J. Biol. Chem. 270: 29682–29689
Knecht, W., Bergjohann, U., Gonski, S., Kirschbaum, B., and Loffler, M., 1996, Functional expression of a fragment of human dihydroorotate dehydrogenase by means of the baculovirus expression vector system, and kinetic investigation of the purified enzyme. Eur. J. Biochem. 240: 292–301
Knecht, W., and Loffler, M., 1998, Species-related inhibition of human and rat dihydroorotate dehydrogenase by immunosuppressive isoxazol and cinchoninic acid derivatives. Biochem. Pharmacol. 56: 1259–1265
Fox, R.I., Herrmann, M.L., Frangou, C.G., Wahl, G.M., Morris, R.E., and Kirschbaum, B.J., 1999, Mechanism of action for leflunomide (Arava ™) in rheumatoid arthritis. Clin. Immunol. 12: 301–315
Chen, S.F., Perrella, F.W., Behrens, D.L., and Papp, L.M., 1992, Inhibiton of dihydroorotate dehydrogenase activity by brequinar sodium. Cancer Res. 52: 3521–3527
Knecht, W., and Loffler, M, 2000, Redoxal as a new leadstructure for dihydroorotate dehydrogenase inhibitors: a kinetic study of the inhibition mechanism. FEBS Letters 467: 27–30.
Knecht, W., Henseling, J., and Loffler, M., 2000, Kinetics of inhibition of human and rat dihydroorotate dehydrogenase by atovaquone, lawsone derivatives, brequinar sodium and polyporic acid. Chem. Biol. Interactions 124: 61–76
Olliaro, P., and Wirth, D., 1997, New targets for antimalarial drug discovery. J. Pharmaceutical Pharmacol. 49: 29–33
Wachsman, M., Hamzeh, F.M., Assadi, N.B., and Lietman, P.S., 1996, Antiviral activity of inhibitors of pyrimidine de novo biosynthesis. Antiviral Chem. Chemother. 7: 7–13
Knecht, W., Altekruse, D., Rotgeri, A., Gonski, S. and Loffler, M., 1997, Rat dihydroorotate dehydrogenase Isolation of the recombinant enzyme from mitochondria of insect cells. Protein Express. Purif. 10: 89–99
Bader, B., Knecht, W., Fries, M., and Loffler, M., 1998, Expression, purification, and characterization of histidine-tagged rat and human flavoenzyme dihydroorotate dehydrogenase. Prot. Exp. Purif. 13: 414–422
Liu, S., Neidhardt, E.A., Grossman, T.H., Ocain, T., and Cardy, J., 2000, Structures of human dihydroorotate dehydrogenase in complex with antiproliferative agents. Structure 8: 25–33
Rowland, P., Norager, S., Jensen, K.F., and Larsen, S., 2000, Crystallization and preliminary X-ray studies of membrane-associated Escherichia coli dihydroorotate dehydrogenase. Acta Cryst. Section D 56: 659–661
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Knecht, W., Loffler, M. (2002). Inhibition and Localization of Human and Rat Dihydroorotate Dehydrogenase. In: Zoref-Shani, E., Sperling, O. (eds) Purine and Pyrimidine Metabolism in Man X. Advances in Experimental Medicine and Biology, vol 486. Springer, Boston, MA. https://doi.org/10.1007/0-306-46843-3_52
Download citation
DOI: https://doi.org/10.1007/0-306-46843-3_52
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-46515-4
Online ISBN: 978-0-306-46843-8
eBook Packages: Springer Book Archive